IRCT20150101020514N24招募中2 期
Evaluating the safety and effectiveness of injectable gel with the Perjunse brand, for correcting nasolabial folds, before and after single clinical trial
Pars Fardad Nano Technology Company0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •18-65 year old men and women
- •Moderate to severe nasolabial folds based on Allergan criteria
- •The opportunity to accompany the visit programs and study process.
- •Signing the informed consent form and agree to a 6-month follow-up
排除标准
- •Previous hyaluronic acid (HA)-based dermal filler treatment(s) injected within the last 12 months prior to enrollment.
- •Cosmetic facial procedures (chemical peel, laser, radio frequency, dermabrasion, ablative or non-ablative procedures), Botox) in the lower 2/3 of the face, within 3 months prior to study entry
- •Planning to undergo any of these procedures at any time during the study
- •Any cosmetic facial procedures during last 3 months
- •Allergy to gram positive bacteria protein, gel ingredients
- •Auto immune or immune deficiency diseases
研究者
相似试验
招募中
2 期
Evaluating the safety and effectiveness of injectable gel with the W&O XtraIII brandIRCT20190210042676N30Ara Teb Gostar Soroush Company30
尚未招募
2 期
Safety and effectiveness assessment of ATP POUYA gel for nasolabial folds correctioSkin aging.IRCT20150101020514N20Pouya Teb Tools Company30
招募中
1 期
Investigating the effect of stromal/mesenchymal stem cell-derived exosomes in patients with perianal fistulaAnal fistulaIRCT20240128060828N1Tehran University of Medical Sciences30
招募中
1 期
Safety and effectiveness assessment of injectable suspension of Inshape x Radiance plus for the treatment of the back of hand wrinklesIRCT20150101020514N31ano Darou Pajouhan Pardis Company15
招募中
2 期
Evaluation of an injectable solution with the brand name ®Embella in order to reduce submental fat.Submental fat.IRCT20190210042676N29Zist orchid pharmed Company20